Paragraph 5

United Kingdom

(1)

After the hearing the reviewers must provide a report to the licensing authority and to the applicant either—

(a)

by the end of the period of 60 days beginning with the day after the conclusion of the hearing; or

(b)

within such further period as the reviewers may notify to the licensing authority and to the applicant within that 60 day period.

(2)

The licensing authority must take the report into account and decide whether—

(a)

to proceed with its proposal to revoke, vary or suspend the licence;

(b)

to confirm or alter its decision;

F1(c)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(d)

to grant or renew the UK marketing authorisation, F2parallel import licence, certificate of registration or traditional herbal registration or to do so otherwise than in accordance with the application; F3...

F4(e)

to revoke, vary or suspend the authorisation, certificate or registration;

(f)

to proceed to suspend, vary or remove a person’s broker registration;

(g)

to proceed to suspend, vary or remove a person’s active substance registration; or

(h)

to proceed to suspend, vary or remove a person’s entry on the list,

as the case may be.

(3)

The licensing authority must notify the applicant of its decision.

Annotations

Textual amendments

F1: Sch. 5 para. 5(2)(c) omitted (31.12.2020) by virtue of The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 22(4); 2020 c. 1, Sch. 5 para. 1(1)
F2: Words in Sch. 5 para. 5(2)(d) inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), regs. 1, 22(2)(a); 2020 c. 1, Sch. 5 para. 1(1)
F3: Word in Sch. 5 para. 5(2)(d) omitted (20.8.2013) by virtue of The Human Medicines (Amendment) Regulations 2013 (S.I. 2013/1855), regs. 1(1), 32(c)(i)
F4: Sch. 5 para. 5(2)(e)-(h) substituted for Sch. 5 para. 5(2)(e) (20.8.2013) by The Human Medicines (Amendment) Regulations 2013 (S.I. 2013/1855), regs. 1(1), 32(c)(ii)